Radical etching apparatus and method
US-9216609-B2 · Dec 22, 2015 · US
US10493793B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10493793-B2 |
| Application number | US-201113639928-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 11, 2011 |
| Priority date | Apr 9, 2010 |
| Publication date | Dec 3, 2019 |
| Grant date | Dec 3, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention is directed to methods for inhibiting growth of bacteria and to nanometer scale surfaces having antibacterial properties.
Opening claim text (preview).
What is claimed is: 1. A method of reducing growth of bacteria on a surface of a polyvinyl chloride substrate comprising: altering the surface of the polyvinyl chloride substrate to produce a nanometer scale surface geometry by: contacting the surface of the polyvinyl chloride substrate with a solution of a nano-roughing agent to produce a nanometer scale surface geometry on the surface of the substrate, and contacting the surface with bacteria, wherein growth of the bacteria on the altered polyvinyl chloride surface is inhibited by about 30% to about 50%, as measured by contacting the altered polyvinyl chloride surface with Staphylococcus aureus bacteria for 4 to 72 hours as compared to contacting the untreated polyvinyl chloride surface with Staphylococcus aureus bacteria for 4 to 72 hours. 2. The method of claim 1 wherein the nano-roughing agent is one or more of an acid, a base, a bacterial lipase, an alcohol, a peroxide, isoamyl acetate, dichloromethane, isoamyl acetate with zinc, dichloromethane with zinc, acetic acid, sulfuric acid, nitric acid, perchloric acid, phosphoric acid, hydrochloric acid, chloroform, acetone, ethanol, ammonia, sodium hydroxide, potassium hydroxide, ammonium hydroxide, ammonium fluoride, hydrofluoric acid, triflic acid, hydrogen peroxide, dichloroethylene, or xylene. 3. The method of claim 1 wherein the nano-roughing agent is one or more of phospholipases, sphingomyelinases, hepatic lipase, endothelial lipase, lipoprotein lipase, bile salt dependent lipase, pancreatic lipase, lysosomal lipase, hormone-sensitive lipase, gastric lipase, pancreatic lipase related protein 2, pancreatic lipase related protein 1, lingual lipase, and bacterial lipase produced from one or more of Rhisopus arrhisus, Candida cilindracea, Candida rugosa, Thermus thermophilus, Candida Antarctica, Aspergillus niger, Aspergillus oryzae, Aspergillus sp, Burkholderia sp, Candida utilis, Chromobacterium viscosum, Mucor javanicus, Penicillium roqueforti , or Pseudomonas cepacia. 4. The method of claim 1 wherein the surface of the substrate is contacted with a solution of Rhisopus arrhisus or Candida cilindracea. 5. The method of claim 1 wherein the substrate further includes a metal, wherein the metal is one or more of titanium, aluminum, platinum, niobium, tantalum, tin, nickel, cobalt, chromium, molybdenum, stainless steel, nitinol, SiN, CoCrMo, or mixtures or alloys thereof. 6. The method of claim 1 wherein the substrate further includes a ceramic, wherein the ceramic is one or more of alumina, hydroxyapatite, silica, calcium phosphates, or bone cements, or composites thereof. 7. The method of claim 1 wherein the substrate is an endotracheal tube. 8. The method of claim 1 wherein the bacteria is one or more of Staphylococcus aureus, Staphylococcus epidermis, Pseudomonas aeruginosa , MRSA, E. coli, candida (yeast), Streptococcus pneumoniae, Neisseria meningitides, Haemophilus influenzae, Streptococcus agalactiae, Listeria monocytogenes, Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophila, Mycobacterium , tuberculosis, Streptococcus pyogenes, Chlamydia trachomatis, Neisseria gonorrhoeae, Treponema pallidum, Ureaplasma urealyticum, Haemophilus ducreyi, Helicobacter pylori, Campylobacter jejuni, Salmonella, Shigella, Clostridium , Enterobacteriaceae, or Staphylococcus saprophyticus. 9. The method of claim 1 , wherein the surface of the substrate includes a metal, wherein the metal is one or more of platinum, tin, molybdenum, stainless steel, SiN, or mixtures or alloys thereof. 10. The method of claim 1 , wherein the surface of the substrate includes a ceramic, wherein the ceramic is one or more of alumina, silica, calcium phosphates, or bone cements, or composites thereof.
Tracheal tubes (catheters in general A61M25/00) · CPC title
Continuous and nonuniform or irregular surface on layer or component [e.g., roofing, etc.] · CPC title
Aqueous compositions · CPC title
by etching · CPC title
Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.